×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ORIC – oric pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ORIC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/13
12:45 am
oric
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
Low
Report
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
11/12
04:05 pm
oric
ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates
Low
Report
ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates
11/4
04:15 pm
oric
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Low
Report
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
11/4
08:19 am
oric
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Medium
Report
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
11/1
04:30 pm
oric
ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Low
Report
ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10/31
07:36 am
oric
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $20.00 price target on the stock.
Low
Report
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $20.00 price target on the stock.
10/23
07:00 am
oric
ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Medium
Report
ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
10/16
08:05 am
oric
Candid Therapeutics Appoints Highly Accomplished Industry Leaders Angie You, Ph.D. and Dan Puckett to it’s Board of Directors
Low
Report
Candid Therapeutics Appoints Highly Accomplished Industry Leaders Angie You, Ph.D. and Dan Puckett to it’s Board of Directors
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
04:05 pm
ORIC
oric pharmaceuticals, inc.
MISS
Report
0.1%
oric pharmaceuticals, inc.
8/12/2024
04:05 pm
ORIC
oric pharmaceuticals, inc.
MISS
Report
6.8%
oric pharmaceuticals, inc.
8/12/2024
04:05 pm
ORIC
oric pharmaceuticals, inc.
MISS
Report
6.8%
oric pharmaceuticals, inc.
8/12/2024
04:05 pm
ORIC
oric pharmaceuticals, inc.
MISS
Report
9.0%
oric pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
05:54 pm
oric
Form SC 13G/A Oric Pharmaceuticals, Filed by: EcoR1 Capital, LLC
Medium
Report
Form SC 13G/A Oric Pharmaceuticals, Filed by: EcoR1 Capital, LLC
11/14
05:48 pm
oric
Form SC 13G/A Oric Pharmaceuticals, Filed by: Nextech Crossover I GP S.a r.l.
Medium
Report
Form SC 13G/A Oric Pharmaceuticals, Filed by: Nextech Crossover I GP S.a r.l.
11/14
05:15 pm
oric
Form SC 13G/A Oric Pharmaceuticals, Filed by: COLUMN GROUP II, LP
Medium
Report
Form SC 13G/A Oric Pharmaceuticals, Filed by: COLUMN GROUP II, LP
11/13
09:43 am
oric
Form SC 13G/A Oric Pharmaceuticals, Filed by: ALKEON CAPITAL MANAGEMENT LLC
Medium
Report
Form SC 13G/A Oric Pharmaceuticals, Filed by: ALKEON CAPITAL MANAGEMENT LLC
11/12
04:21 pm
oric
Form 10-Q Oric Pharmaceuticals, For: Sep 30
Low
Report
Form 10-Q Oric Pharmaceuticals, For: Sep 30
11/12
04:11 pm
oric
Form 8-K Oric Pharmaceuticals, For: Nov 12
Low
Report
Form 8-K Oric Pharmaceuticals, For: Nov 12
11/12
10:33 am
oric
Form SC 13G/A Oric Pharmaceuticals, Filed by: FMR LLC
Low
Report
Form SC 13G/A Oric Pharmaceuticals, Filed by: FMR LLC
11/8
02:21 pm
oric
Form SC 13G Oric Pharmaceuticals, Filed by: BlackRock, Inc.
Low
Report
Form SC 13G Oric Pharmaceuticals, Filed by: BlackRock, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: